about
P184
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cellsT-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalTumor cell resistance to DNA-damaging agents: from apoptosis to neiosis.New insights into the kinetic resistance to anticancer agentsTumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients.CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer.Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity.Human FOXP3 and cancer.Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer.Role of myeloid-derived suppressor cells in tumor immunotherapy.Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth.5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.DNA-damaged polyploid cancer cells can reverse to diploidy: an ordered, but little understood, process of genomic reduction [with reference to the previous comments of Forer (2008) and Wheatley (2008a and b)].Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy.A novel dendritic cell subset involved in tumor immunosurveillance.CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative.[Th9 cells: a new population of helper T cells].An atypical caspase-independent death pathway for an immunogenic cancer cell line.
P50
Q33604925-FBC3AD81-3DCA-45F7-869F-311663D1C14BQ35212682-DD59A41C-2075-4548-8FCD-2F0CE1C4D929Q35901164-2F17D782-D66E-4F94-B389-F483C7438156Q36254839-CACAE64E-95E4-4A95-A6F0-F268FFBEB88CQ36403539-B2C75308-195F-4916-835D-247D7DB69D69Q36403637-8056CB27-2CF3-4438-974C-D3424B280E71Q36710911-636FCDD0-4F0F-4300-9C1D-F23096069012Q36915014-B033AE98-7E82-4B5B-A35F-ECEE94ED8F42Q37120261-C3613CAF-295C-44E3-99BA-1DCACA4BEDFAQ37760416-EC354DB4-159C-4B9D-A121-7587DC6CFD79Q37885285-4CD60A21-E3C0-4C17-B28B-A088BBD678B3Q37965750-B0AC33AE-3735-445E-B491-6B5C90CF9A97Q38053539-664415B4-68CD-4D38-9568-1E0AAE0763A6Q39234393-2BAB8BA4-7067-48B9-9C33-583E27DF6E96Q39715226-31470EBF-1CCC-42E7-A8EC-74FEEBF8F26FQ39869900-984AE925-28DE-4637-B4D7-79B61F4FC69DQ39972815-F775F4B1-A661-4745-A6E6-CFDEBE11F58BQ40323661-5CD1436F-E66B-4473-81A3-C2F6077A4641Q40591372-39BD65B1-B719-4F0A-B061-387C2AFB1FB9Q40690742-2A49B75E-ECE6-486F-8A34-1D19452BEEE7Q40707613-698E210C-9A14-4422-8FBD-F56DA04E892F
P50
description
onderzoeker
@nl
name
François Martin
@ast
François Martin
@en
François Martin
@es
François Martin
@fr
François Martin
@sl
type
label
François Martin
@ast
François Martin
@en
François Martin
@es
François Martin
@fr
François Martin
@sl
prefLabel
François Martin
@ast
François Martin
@en
François Martin
@es
François Martin
@fr
François Martin
@sl
P214
P269
P106
P185
P21
P214
P269
P31
P569
1950-01-01T00:00:00Z
P734
P735
P7859
viaf-220152613